A. The effectiveness of peptides varies dramatically by compound and intended use. For tanning (melanotan), peptides do work, ...

Trends around longevity and functional strength were already pushing more people toward resistance training, Severin says, but GLP-1s added a clinical urgency because they’re associated with a loss of ...

If you've been curious about weight loss medications but feel overwhelmed by all the options, you're not alone. With so many ...

Researchers boosted levels of a heart-healing hormone in mice and pigs with a single injection of a new, experimental form of self-amplifying RNA that prolonged hormone synthesis for many weeks. When ...

The Kroger Family of Pharmacies honor manufacturer-sponsored programs, including Lilly's KwikPen Self-Pay Savings Card for Zepbound®, according to each program's eligibility requirements and terms and ...

The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device. Lilly says the new pen expands patient choice, ...

Used by millions of patients worldwide, the KwikPen® for single-patient use provides patients with a new option to receive Zepbound® Zepbound patients can access all doses in either multi-dose KwikPen ...

About a month after securing a label expansion from the FDA for multidose pen versions of Zepbound, Eli Lilly is making the KwikPens available to self-paying users of its direct-to-consumer drug sales ...

Eli Lilly, the drugmaker behind weight-loss treatments Mounjaro and Zepbound, has rapidly overtaken former market leader Novo Nordisk in the obesity drug race. While Novo’s shares have struggled this ...

Today, Eli Lilly launched a four-dose, single-patient use KwikPen device for its injectable obesity drug, tirzepatide (Zepbound). The device gives patients an additional, potentially more convenient ...

TrumpRx, the Trump administration's much-anticipated direct-to-consumer drug platform, went live on Thursday. A key pillar of President Donald Trump's effort to lower prescription drug costs, the ...